Sun Pharma signs Definitive Agreement to Acquire Organon

Contributed by: Business Wire

Tags

Health

Consumer

Women

General Health

Pharmaceutical

Biotechnology

Sun Pharma

More Like This

Organigram to Acquire Aurora and Establish a Global Cannabis Leader

GlobeNewswire associated0

Olon Continues its Growth Path and Announces a New Acquisition

GlobeNewswire associated0

THEON Enters into Exclusivity Agreement for the Acquisition of HGH Systèmes Infrarouges, Accelerating Expansion into Multi-Domain ISR & Counter-UAS Solutions

Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany

European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

PR Newswire associated0

OCI N.V. recommends the unsolicited all-cash Offer from NNS at EUR 4.10 per share. The Court-appointed Directors consent to the convocation of an extraordinary general meeting to submit the OCI-Orascom transaction to a shareholder vote.

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)

Merck Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio